- Home
- CIO vs CVRX Comparison
CIO vs CVRX Comparison
Compare CIO & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIO
- CVRX
- Stock Information
- Founded
- CIO 2013
- CVRX 2000
- Country
- CIO Canada
- CVRX United States
- Employees
- CIO N/A
- CVRX N/A
- Industry
- CIO Real Estate Investment Trusts
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CIO Real Estate
- CVRX Health Care
- Exchange
- CIO Nasdaq
- CVRX Nasdaq
- Market Cap
- CIO 221.6M
- CVRX 177.4M
- IPO Year
- CIO 2014
- CVRX 2021
- Fundamental
- Price
- CIO $6.94
- CVRX $7.03
- Analyst Decision
- CIO Hold
- CVRX Buy
- Analyst Count
- CIO 1
- CVRX 7
- Target Price
- CIO N/A
- CVRX $14.00
- AVG Volume (30 Days)
- CIO 1.2M
- CVRX 307.9K
- Earning Date
- CIO 07-31-2025
- CVRX 08-04-2025
- Dividend Yield
- CIO 5.76%
- CVRX N/A
- EPS Growth
- CIO N/A
- CVRX N/A
- EPS
- CIO N/A
- CVRX N/A
- Revenue
- CIO $168,892,000.00
- CVRX $54,652,000.00
- Revenue This Year
- CIO $1.13
- CVRX $11.53
- Revenue Next Year
- CIO $3.73
- CVRX $18.61
- P/E Ratio
- CIO N/A
- CVRX N/A
- Revenue Growth
- CIO N/A
- CVRX 23.11
- 52 Week Low
- CIO $4.19
- CVRX $4.30
- 52 Week High
- CIO $6.99
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- CIO 77.33
- CVRX 44.46
- Support Level
- CIO $6.91
- CVRX $6.15
- Resistance Level
- CIO $6.99
- CVRX $7.83
- Average True Range (ATR)
- CIO 0.03
- CVRX 0.53
- MACD
- CIO -0.04
- CVRX -0.10
- Stochastic Oscillator
- CIO 33.33
- CVRX 33.08
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.